Entrada Therapeutics Inc. (TRDA)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
6. 89
+0.02
+0.2911%
$
263.98M Market Cap
- P/E Ratio
- Div Yield
378,200 Volume
-2.5 Eps
$ 6.87
Previous Close 
Want to track TRDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Entrada Therapeutics Inc. (TRDA) Statistics
Valuation metrics
Market Cap 263.98M
Enterprise value 240.78M
Trailing P/E (ttm) -1.72
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 46.61
Price/Book (mrq) 1.06
Enterprise Value/Revenue 41.96
Enterprise Value/EBITDA -1.46
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 377.07K
Average volume (90 days) 528.14K
Price summary
52-Week low 4.93
52-Week high 16.45
Beta -
50-Day moving average 6.84
200-Day moving average 11.17
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -28.95%
Operating margin -31.09%
Operational effectiveness
Return on assets -0.5%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.14
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.97
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.09
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 13.9%
Book value per share (mrq) 6.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
